We are live on
!
Find out more
VCNX
Vaccinex, Inc. Common Stock
VCNX
VCNX
Delisted
VCNX was delisted on the 17th of December, 2024.
12 hedge funds and large institutions have $2.39M invested in Vaccinex, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 0 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
124% more capital invested
Capital invested by funds: $1.07M → $2.39M (+$1.32M)
29% less funds holding
Funds holding: 17 → 12 (-5)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Holders
12
Holders Change
-5
Holders Change %
-29.41%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
8
Reduced
–
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$1.26M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.01M |
| 3 |
Morgan Stanley
New York
|
+$9.63K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.94K |
| 5 |
TC
Tacita Capital
Toronto,
Ontario, Canada
|
+$1.98K |
Top Sellers
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$435K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$32.1K |
| 3 |
Renaissance Technologies
New York
|
-$21K |
| 4 |
Two Sigma Investments
New York
|
-$10.7K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$10.7K |
